S&P 500   4,566.48
DOW   35,741.15
QQQ   377.93
S&P 500   4,566.48
DOW   35,741.15
QQQ   377.93
S&P 500   4,566.48
DOW   35,741.15
QQQ   377.93
S&P 500   4,566.48
DOW   35,741.15
QQQ   377.93

McKesson Stock Forecast, Price & News

-1.64 (-0.78 %)
(As of 10/25/2021 04:00 PM ET)
Today's Range
50-Day Range
52-Week Range
Volume628,967 shs
Average Volume1.02 million shs
Market Capitalization$32.09 billion
P/E RatioN/A
Dividend Yield0.90%
30 days | 90 days | 365 days | Advanced Chart
Receive MCK News and Ratings via Email

Sign-up to receive the latest news and ratings for McKesson and its competitors with MarketBeat's FREE daily newsletter.

McKesson logo

About McKesson

McKesson Corp. engages in the provision of supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. It operates through the following segments: U.S. Pharmaceutical; International; Medical-Surgical Solutions; and Prescription Technology Solutions (“RxTS“). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; provides practice management, technology, clinical support, and business solutions to community-based oncology, and other specialty practices; and sells financial, operational, and clinical solutions to pharmacies and provides consulting, outsourcing, technological, and other services. The International segment provides distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The RxTS


See More Headlines

Industry, Sector and Symbol

Drugs, proprietaries, & sundries
Health Care Distributors
Year Founded

Sales & Book Value

Annual Sales
$238.23 billion
Cash Flow
$25.18 per share
Book Value
$1.10 per share


Net Income
$-4.54 billion




Market Cap
$32.09 billion
Next Earnings Date
11/1/2021 (Confirmed)

Social Links


Overall MarketRank

2.40 out of 5 stars

Medical Sector

178th out of 1,360 stocks

Drugs, Proprietaries, & Sundries Industry

5th out of 7 stocks

Analyst Opinion: 1.4Community Rank: 5.0Dividend Strength: 2.5Insider Behavior: 2.5Valuation: 0.6 5 -4 -3 -2 -1 -

McKesson (NYSE:MCK) Frequently Asked Questions

Is McKesson a buy right now?

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for McKesson in the last year. There are currently 2 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" McKesson stock.
View analyst ratings for McKesson
or view top-rated stocks.

What stocks does MarketBeat like better than McKesson?

Wall Street analysts have given McKesson a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but McKesson wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting McKesson?

McKesson saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 2,400,000 shares, an increase of 17.1% from the August 31st total of 2,050,000 shares. Based on an average daily trading volume, of 1,060,000 shares, the days-to-cover ratio is currently 2.3 days. Approximately 1.6% of the company's stock are sold short.
View McKesson's Short Interest

When is McKesson's next earnings date?

McKesson is scheduled to release its next quarterly earnings announcement on Monday, November 1st 2021.
View our earnings forecast for McKesson

How can I listen to McKesson's earnings call?

McKesson will be holding an earnings conference call on Monday, November 1st at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

How were McKesson's earnings last quarter?

McKesson Co. (NYSE:MCK) announced its earnings results on Wednesday, August, 4th. The company reported $5.56 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $4.09 by $1.47. The business had revenue of $62.67 billion for the quarter, compared to the consensus estimate of $60.16 billion. McKesson had a positive trailing twelve-month return on equity of 216.39% and a negative net margin of 1.83%. The business's revenue for the quarter was up 12.6% on a year-over-year basis. During the same period last year, the firm posted $2.77 EPS.
View McKesson's earnings history

How has McKesson's stock been impacted by COVID-19 (Coronavirus)?

McKesson's stock was trading at $135.17 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, MCK stock has increased by 53.5% and is now trading at $207.45.
View which stocks have been most impacted by COVID-19

How often does McKesson pay dividends? What is the dividend yield for McKesson?

McKesson declared a quarterly dividend on Monday, July 26th. Stockholders of record on Wednesday, September 1st will be given a dividend of $0.47 per share on Friday, October 1st. This represents a $1.88 dividend on an annualized basis and a dividend yield of 0.91%. The ex-dividend date is Tuesday, August 31st. This is an increase from McKesson's previous quarterly dividend of $0.42.
View McKesson's dividend history

Is McKesson a good dividend stock?

McKesson pays an annual dividend of $1.88 per share and currently has a dividend yield of 0.90%. McKesson has been increasing its dividend for 5 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio of McKesson is 10.92%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, McKesson will have a dividend payout ratio of 8.91% next year. This indicates that McKesson will be able to sustain or increase its dividend.
View McKesson's dividend history.

How will McKesson's stock buyback program work?

McKesson announced that its board has authorized a share repurchase plan on Tuesday, February 2nd 2021, which allows the company to buyback $2,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization allows the company to purchase up to 6.9% of its stock through open market purchases. Stock buyback plans are usually an indication that the company's management believes its shares are undervalued.

What guidance has McKesson issued on next quarter's earnings?

McKesson issued an update on its FY 2022 earnings guidance on Wednesday, September, 1st. The company provided earnings per share guidance of $19.800-$20.400 for the period, compared to the Thomson Reuters consensus estimate of $19.230. The company issued revenue guidance of $247.76 billion-$254.90 billion, compared to the consensus revenue estimate of $249.75 billion.

What price target have analysts set for MCK?

8 equities research analysts have issued 1-year price objectives for McKesson's shares. Their forecasts range from $166.00 to $261.00. On average, they anticipate McKesson's stock price to reach $224.13 in the next year. This suggests a possible upside of 8.0% from the stock's current price.
View analysts' price targets for McKesson
or view top-rated stocks among Wall Street analysts.

Who are McKesson's key executives?

McKesson's management team includes the following people:
  • Brian Scott Tyler, Chief Executive Officer & Director
  • Britt J. Vitalone, Chief Financial Officer & Executive Vice President
  • Nancy Flores, Chief Technology & Information Officer, EVP
  • Tracy Faber, Chief Human Resources Officer & Executive VP
  • Lori A. Schechter, Chief Legal Officer, EVP & General Counsel

What is Brian Tyler's approval rating as McKesson's CEO?

220 employees have rated McKesson CEO Brian Tyler on Glassdoor.com. Brian Tyler has an approval rating of 88% among McKesson's employees.

Who are some of McKesson's key competitors?

What other stocks do shareholders of McKesson own?

Based on aggregate information from My MarketBeat watchlists, some companies that other McKesson investors own include The Walt Disney (DIS), Johnson & Johnson (JNJ), Gilead Sciences (GILD), CVS Health (CVS), AbbVie (ABBV), Bank of America (BAC), AT&T (T), JPMorgan Chase & Co. (JPM), UnitedHealth Group (UNH) and The Home Depot (HD).

What is McKesson's stock symbol?

McKesson trades on the New York Stock Exchange (NYSE) under the ticker symbol "MCK."

Who are McKesson's major shareholders?

McKesson's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Scharf Investments LLC (0.56%), Robeco Institutional Asset Management B.V. (0.39%), Sumitomo Mitsui Trust Holdings Inc. (0.30%), Strs Ohio (0.25%), Assenagon Asset Management S.A. (0.20%) and PGGM Investments (0.19%). Company insiders that own McKesson stock include Brian S Tyler, Britt J Vitalone, Lori A Schechter, Marie L/Ca Knowles, Sundeep G Reddy, Thomas L Rodgers and Tracy Faber.
View institutional ownership trends for McKesson

Which major investors are selling McKesson stock?

MCK stock was sold by a variety of institutional investors in the last quarter, including Strs Ohio, Spire Wealth Management, Robeco Institutional Asset Management B.V., Sumitomo Mitsui Trust Holdings Inc., Pensionfund DSM Netherlands, PGGM Investments, Wedge Capital Management L L P NC, and Chevy Chase Trust Holdings Inc.. Company insiders that have sold McKesson company stock in the last year include Brian S Tyler, Britt J Vitalone, Lori A Schechter, Sundeep G Reddy, Thomas L Rodgers, and Tracy Faber.
View insider buying and selling activity for McKesson
or view top insider-selling stocks.

Which major investors are buying McKesson stock?

MCK stock was acquired by a variety of institutional investors in the last quarter, including Private Advisor Group LLC, Campbell Capital Management Inc., Park National Corp OH, Pacer Advisors Inc., Kestra Advisory Services LLC, DekaBank Deutsche Girozentrale, Signature Estate & Investment Advisors LLC, and Scharf Investments LLC.
View insider buying and selling activity for McKesson
or or view top insider-buying stocks.

How do I buy shares of McKesson?

Shares of MCK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is McKesson's stock price today?

One share of MCK stock can currently be purchased for approximately $207.45.

How much money does McKesson make?

McKesson has a market capitalization of $32.09 billion and generates $238.23 billion in revenue each year. The company earns $-4.54 billion in net income (profit) each year or $17.21 on an earnings per share basis.

How many employees does McKesson have?

McKesson employs 67,500 workers across the globe.

Does McKesson have any subsidiaries?

The following companies are subsidiares of McKesson: A.L.I. Technologies, AMISYS Managed Care Systems, Abaton.com, Access Health, Biologics, Celesio, ClarusONE Sourcing Services LLP, CoverMyMeds, D & K Healthcare Resources, Drug Trading Co. Ltd., EN-Chart Scanning Program, Emendo, Enterprise Systems Inc., HBO & Company, HPR, HealthCom Partners, HealthQx, IMNET Systems, LloydsDirect, MED3000, McKesson Europe AG, McKesson International Bermuda IP5A Limited, McKesson Medical-Surgical Inc., McKesson Medical-Surgical Supply Chain Services LLC, McKesson Sourcing Services Inc., McKesson Specialty Care Distribution LLC, McKesson Strategic Services Limited, McKesson UK Finance I Limited, McKesson US Finance Corporation, McQueary Brothers, MedVentive, Medcon, MediVation Inc., Medical Specialties Distributors, Medis Health And Pharmaceutical Services, Moore Medical, NDCHealth, Northstar Healthcare Holdings Unlimited Company, Oncology Therapeutics Network, PSS World Medical, Per-Se Technologies, Portico Systems, Practice Partner, RedLine HealthCare, RelayHealth, Rexall, Rosebud Solutions, RxCrossroads, Sterling Medical Services LLC, UDG Healthcare, US Oncology, US Oncology Holdings Inc., Vantage Oncology, Vivalog Technologies, Well.ca, and peerVue.

When was McKesson founded?

McKesson was founded in 1833.

What is McKesson's official website?

The official website for McKesson is www.mckesson.com.

Where are McKesson's headquarters?

McKesson is headquartered at 6555 STATE HWY 161, IRVING TX, 75039.

How can I contact McKesson?

McKesson's mailing address is 6555 STATE HWY 161, IRVING TX, 75039. The company can be reached via phone at (972) 446-4800 or via email at [email protected].

This page was last updated on 10/26/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.